Page last updated: 2024-08-21

malondialdehyde and Addiction, Opioid

malondialdehyde has been researched along with Addiction, Opioid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmadi, S; Khazaie, H; Kiani, A; Moini, A; Najafi, K; Rahpeyma, M; Vaisi-Raygani, A1
Aghadavod, E; Asemi, Z; Bahmani, F; Banafshe, HR; Ghaderi, A; Karimi, MA; Mansournia, MA; Mehrzad, F; Mirhosseini, N; Motmaen, M; Reiter, RJ1
Abdel-Rahman, MS; Abdel-Zaher, AO; Elwasei, FM1
Atici, S; Cinel, I; Cinel, L; Doruk, N; Eskandari, G; Oral, U1
Antonova, TV; Bol'shakova, AI; Nikolaenko, SL1

Trials

1 trial(s) available for malondialdehyde and Addiction, Opioid

ArticleYear
The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment.
    Addiction biology, 2019, Volume: 24, Issue:4

    Topics: Adult; Analgesics, Opioid; Antioxidants; Anxiety; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Depression; Double-Blind Method; Gene Expression; Glutathione; Humans; Insulin Resistance; Interleukin-1; Male; Malondialdehyde; Melatonin; Mental Health; Methadone; Middle Aged; Nitric Oxide; Opiate Substitution Treatment; Opioid-Related Disorders; Penile Erection; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sleep; Transforming Growth Factor beta; Triglycerides; Tumor Necrosis Factor-alpha

2019

Other Studies

4 other study(ies) available for malondialdehyde and Addiction, Opioid

ArticleYear
Study of Serum Malondialdehyde Level in Opioid and Methamphetamine Dependent Patients.
    Acta medica Iranica, 2017, Volume: 55, Issue:10

    Topics: Amphetamine-Related Disorders; Analgesics, Opioid; Antioxidants; Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Lipid Peroxidation; Malondialdehyde; Methamphetamine; Opioid-Related Disorders; Oxidative Stress; Thiobarbiturates

2017
Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress.
    Neurotoxicology, 2011, Volume: 32, Issue:6

    Topics: Analgesics, Opioid; Animals; Antioxidants; Behavior, Animal; Brain; Drug Tolerance; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Male; Malondialdehyde; Mice; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Opioid-Related Disorders; Oxidative Stress; Pain Threshold; Plant Oils; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Time Factors; Tramadol

2011
Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model.
    Journal of biosciences, 2005, Volume: 30, Issue:2

    Topics: Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Kidney; L-Lactate Dehydrogenase; Lipid Peroxides; Liver; Male; Malondialdehyde; Morphine; Opioid-Related Disorders; Rats; Rats, Wistar; Tramadol

2005
[Characteristics of viral hepatitis in addicts with consideration of lymphocyte membrane condition].
    Terapevticheskii arkhiv, 1998, Volume: 70, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Biomarkers; Cell Membrane; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lipid Peroxidation; Lymphocytes; Male; Malondialdehyde; Opioid-Related Disorders; Severity of Illness Index; Substance Abuse, Intravenous; Superoxide Dismutase

1998